Latest BOONE CAPITAL MANAGEMENT LLC Stock Portfolio
BOONE CAPITAL MANAGEMENT LLC Performance:
2025 Q3: 6.86%YTD: 8.81%2024: 5.75%
Performance for 2025 Q3 is 6.86%, and YTD is 8.81%, and 2024 is 5.75%.
About BOONE CAPITAL MANAGEMENT LLC and 13F Hedge Fund Stock Holdings
BOONE CAPITAL MANAGEMENT LLC is a hedge fund based in ATLANTA, GA. On 10-May-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $414 Millions. In it's latest 13F Holdings report, BOONE CAPITAL MANAGEMENT LLC reported an equity portfolio of $305 Millions as of 30 Sep, 2025.
The top stock holdings of BOONE CAPITAL MANAGEMENT LLC are MDT, MIRM, IONS. The fund has invested 13.4% of it's portfolio in MEDTRONIC PLC and 12.9% of portfolio in MIRUM PHARMACEUTICALS INC.
The fund managers got completely rid off AVANTOR INC (AVTR), UNUM GROUP (UNM) and PENNANT GROUP INC (PNTG) stocks. They significantly reduced their stock positions in ABEONA THERAPEUTICS INC (ABEO), BIOMARIN PHARMACEUTICAL INC (BMRN) and MIRUM PHARMACEUTICALS INC (MIRM). BOONE CAPITAL MANAGEMENT LLC opened new stock positions in IONIS PHARMACEUTICALS INC (IONS), BRIDGEBIO PHARMA INC (BBIO) and RAPT THERAPEUTICS INC (RAPT). The fund showed a lot of confidence in some stocks as they added substantially to THE CIGNA GROUP (CI).
The top stock holdings of BOONE CAPITAL MANAGEMENT LLC are MDT, MIRM, IONS. The fund has invested 13.4% of it's portfolio in MEDTRONIC PLC and 12.9% of portfolio in MIRUM PHARMACEUTICALS INC.
The fund managers got completely rid off AVANTOR INC (AVTR), UNUM GROUP (UNM) and PENNANT GROUP INC (PNTG) stocks. They significantly reduced their stock positions in ABEONA THERAPEUTICS INC (ABEO), BIOMARIN PHARMACEUTICAL INC (BMRN) and MIRUM PHARMACEUTICALS INC (MIRM). BOONE CAPITAL MANAGEMENT LLC opened new stock positions in IONIS PHARMACEUTICALS INC (IONS), BRIDGEBIO PHARMA INC (BBIO) and RAPT THERAPEUTICS INC (RAPT). The fund showed a lot of confidence in some stocks as they added substantially to THE CIGNA GROUP (CI).
BOONE CAPITAL MANAGEMENT LLC Annual Return Estimates Vs S&P 500
Our best estimate is that BOONE CAPITAL MANAGEMENT LLC made a return of 6.86% in the last quarter. In trailing 12 months, it's portfolio return was 6.74%.
New Buys
| Ticker | $ Bought |
|---|---|
| ionis pharmaceuticals inc | 27,334,600 |
| bridgebio pharma inc | 23,907,000 |
| rapt therapeutics inc | 20,179,700 |
| cogent biosciences inc | 13,570,800 |
| kodiak sciences inc | 11,718,900 |
| livanova plc | 8,796,280 |
| uniqure nv | 8,598,890 |
| clearpoint neuro inc | 6,186,440 |
New stocks bought by BOONE CAPITAL MANAGEMENT LLC
Additions
| Ticker | % Inc. |
|---|---|
| the cigna group | 133 |
Additions to existing portfolio by BOONE CAPITAL MANAGEMENT LLC
Reductions
| Ticker | % Reduced |
|---|---|
| abeona therapeutics inc | -59.92 |
| biomarin pharmaceutical inc | -26.57 |
| mirum pharmaceuticals inc | -16.48 |
| neurocrine biosciences inc | -7.72 |
BOONE CAPITAL MANAGEMENT LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| avantor inc | -22,807,700 |
| pennant group inc | -19,373,300 |
| unum group | -22,757,400 |
BOONE CAPITAL MANAGEMENT LLC got rid off the above stocks
Sector Distribution
BOONE CAPITAL MANAGEMENT LLC has about 94.5% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 94.5 |
| Others | 5.5 |
Market Cap. Distribution
BOONE CAPITAL MANAGEMENT LLC has about 41.3% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 34.7 |
| SMALL-CAP | 20.1 |
| MID-CAP | 19.7 |
| MICRO-CAP | 13.4 |
| MEGA-CAP | 6.6 |
| UNALLOCATED | 5.5 |
Stocks belong to which Index?
About 68.3% of the stocks held by BOONE CAPITAL MANAGEMENT LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 40.5 |
| Others | 31.6 |
| S&P 500 | 27.8 |
BOONE CAPITAL MANAGEMENT LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of BOONE CAPITAL MANAGEMENT LLC
BOONE CAPITAL MANAGEMENT LLC has 16 stocks in it's portfolio. About 83.1% of the portfolio is in top 10 stocks. CI proved to be the most loss making stock for the portfolio. MIRM was the most profitable stock for BOONE CAPITAL MANAGEMENT LLC last quarter.
Last Reported on: 14 Nov, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABEO | abeona therapeutics inc | 0.87 | 502,854 | 2,655,070 | reduced | -59.92 | ||
| AVTR | avantor inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BBIO | bridgebio pharma inc | 7.84 | 460,282 | 23,907,000 | new | |||
| BMRN | biomarin pharmaceutical inc | 5.84 | 328,546 | 17,794,100 | reduced | -26.57 | ||
| CI | the cigna group | 7.84 | 82,972 | 23,916,700 | added | 133 | ||
| CLPT | clearpoint neuro inc | 2.03 | 283,912 | 6,186,440 | new | |||
| COGT | cogent biosciences inc | 4.45 | 945,042 | 13,570,800 | new | |||
| IONS | ionis pharmaceuticals inc | 8.96 | 417,833 | 27,334,600 | new | |||
| KOD | kodiak sciences inc | 3.84 | 715,877 | 11,718,900 | new | |||
| LIVN | livanova plc | 2.88 | 167,932 | 8,796,280 | new | |||
| MDT | medtronic plc | 13.39 | 428,789 | 40,837,900 | unchanged | 0.00 | ||
| MIRM | mirum pharmaceuticals inc | 12.88 | 535,732 | 39,274,500 | reduced | -16.48 | ||
| NBIX | neurocrine biosciences inc | 7.66 | 166,414 | 23,361,200 | reduced | -7.72 | ||
| PNTG | pennant group inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| QURE | uniqure nv | 2.82 | 147,317 | 8,598,890 | new | |||
| RAPT | rapt therapeutics inc | 6.62 | 782,461 | 20,179,700 | new | |||
| UNH | unitedhealth group inc | 6.58 | 58,112 | 20,066,100 | unchanged | 0.00 | ||
| UNM | unum group | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| icon plc | 5.50 | 95,832 | 16,770,600 | unchanged | 0.00 | |||